PRESCRIPTION DRUG IMPORT ACT
Consumers may have access to lower-cost prescription drugs imported from Canada.
Do you support it?
Want to know if it passes?
We'll email you when SB 2893 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on SB 2893.
You're tracking SB 2893
We'll email you the moment it moves.
SB 2893 — PRESCRIPTION DRUG IMPORT ACT
Last action — Rule 3-9(a) / Re-referred to Assignments
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 103rd Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
In plain language
Establishes a program to import prescription drugs from Canada to save consumers money.
The Wholesale Prescription Drug Importation Program Act mandates the Department of Public Health to create a program for importing prescription drugs from Canada. This program aims to provide cost savings to consumers by requiring the development of registration processes, drug lists, and compliance with federal safety standards.
What this means for you
- Consumers: Consumers may have access to lower-cost prescription drugs imported from Canada.
Summary
Creates the Wholesale Prescription Drug Importation Program Act. Requires the Department of Public Health to establish the Wholesale Prescription Drug Importation Program. Provides that the Department shall implement the program by: (1) contracting with one or more prescription drug wholesalers and Canadian suppliers to import prescription drugs and provide prescription drug cost savings to consumers in this State; (2) developing a registration process for health benefit plan issuers, health care providers, and pharmacies to obtain and dispense prescription drugs imported under the program; (3) developing a list of prescription drugs, including the prices of those drugs, that meet certain requirements set forth under the Act and publishing the list on the Department's website; (4) establishing an outreach and marketing plan to generate program awareness; (5) ensuring the program and the prescription drug wholesalers that contract with this State comply with certain federal tracking, tracing, verification, and identification requirements; and other matters. Sets forth eligibility criteria for prescription drugs that may be imported into the State under the program. Contains provisions concerning anticompetitive behavior monitoring; program funding; audit procedures; annual reporting requirements; the adoption of rules to implement the Act; and federal waiver or authorization requirements. Effective July 1, 2024.
Bill Text
- Introduced View text Current pdf
Amendments
1 amendmentClick Show changes on an amendment above to see how it modifies the bill.
Action History
-
Rule 3-9(a) / Re-referred to Assignments
-
Senate Committee Amendment No. 1 Pursuant to Senate Rule 3-8(b-1), the following amendment will remain in the Committee on Assignments.
-
Senate Committee Amendment No. 1 Referred to Assignments
-
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Karina Villa
-
Added as Co-Sponsor Sen. Paul Faraci
-
Postponed - Public Health
-
Added as Co-Sponsor Sen. Rachel Ventura
-
Added as Chief Co-Sponsor Sen. Lakesia Collins
-
Added as Chief Co-Sponsor Sen. Robert Peters
-
Added as Co-Sponsor Sen. Natalie Toro
-
Added as Co-Sponsor Sen. Ram Villivalam
-
Added as Co-Sponsor Sen. Michael W. Halpin
-
Added as Co-Sponsor Sen. Javier L. Cervantes
-
Added as Co-Sponsor Sen. Mary Edly-Allen
-
Assigned to Public Health
-
Directed to Multiple Committees Public Health; Appropriations
-
Referred to Assignments
-
First Reading
-
Filed with Secretary by Sen. Karina Villa
Sponsors
- Karina Villa · Primary
- Robert Peters · Cosponsor
- Lakesia Collins · Cosponsor
- Mary Edly-Allen · Cosponsor
- Javier L. Cervantes · Cosponsor
- Michael W. Halpin · Cosponsor
- Ram Villivalam · Cosponsor
- Natalie Toro · Cosponsor
- Rachel Ventura · Cosponsor
- Paul Faraci · Cosponsor
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 9 co-sponsors · 173 not signed on
Sponsors (1)
- Karina Villa Democrat
Co-sponsors (9)
- Robert Peters Democrat
- Lakesia Collins Democrat
- Mary Edly-Allen Democrat
- Javier L. Cervantes Democrat
- Michael W. Halpin Democrat
- Ram Villivalam Democrat
- Natalie Toro
- Rachel Ventura Democrat
- Paul Faraci Democrat
Not signed on (173)
173 members have not signed on to this bill.
Show all 173 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 2893 do?
- Creates the Wholesale Prescription Drug Importation Program Act. Requires the Department of Public Health to establish the Wholesale Prescription Drug Importation Program. Provides that the Department shall implement the program by: (1) contracting with one or more prescription drug wholesalers and Canadian suppliers to import prescription drugs and provide prescription drug cost savings to consumers in this State; (2) developing a registration process for health benefit plan issuers, health care providers, and pharmacies to obtain and dispense prescription drugs imported under the program; (3) developing a list of prescription drugs, including the prices of those drugs, that meet certain requirements set forth under the Act and publishing the list on the Department's website; (4) establishing an outreach and marketing plan to generate program awareness; (5) ensuring the program and the prescription drug wholesalers that contract with this State comply with certain federal tracking, tracing, verification, and identification requirements; and other matters. Sets forth eligibility criteria for prescription drugs that may be imported into the State under the program. Contains provisions concerning anticompetitive behavior monitoring; program funding; audit procedures; annual reporting requirements; the adoption of rules to implement the Act; and federal waiver or authorization requirements. Effective July 1, 2024.
- Who sponsors SB 2893?
- SB 2893 is sponsored by Karina Villa (Democrat), Robert Peters (Democrat), Lakesia Collins (Democrat), Mary Edly-Allen (Democrat), Javier L. Cervantes (Democrat), Michael W. Halpin (Democrat), Ram Villivalam (Democrat), Natalie Toro, Rachel Ventura (Democrat), and Paul Faraci (Democrat).
- What is the current status of SB 2893?
- This bill died with 103rd Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 2893?
- Track SB 2893 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 2893
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 2893
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →